1
|
Shawahna R and Jaradat NA:
Ethnopharmacological survey of medicinal plants used by patients
with psoriasis in the West Bank of Palestine. BMC Complement Altern
Med. 17:4–13. 2017.PubMed/NCBI View Article : Google Scholar
|
2
|
Yang L, Zhang CS, May B, Yu J, Guo X,
Zhang AL, Xue CC and Lu C: Efficacy of combining oral Chinese
herbal medicine and NB-UVB in treating psoriasis vulgaris: A
systematic review and meta-analysis. Chin Med. 10:27–41.
2015.PubMed/NCBI View Article : Google Scholar
|
3
|
Meng S, Lin Z, Wang Y, Wang Z, Li P and
Zheng Y: Psoriasis therapy by Chinese medicine and modern agents.
Chin Med. 13:16–26. 2018.PubMed/NCBI View Article : Google Scholar
|
4
|
Grigore O, Mihailescu AI, Solomon I, Boda
D and Caruntu C: Role of stress in modulation of skin neurogenic
inflammation. Exp Ther Med. 17:997–1003. 2019.PubMed/NCBI View Article : Google Scholar
|
5
|
Ilie MA, Caruntu C, Lixandru D, Tampa M,
Georgescu SR, Constantin MM, Constantin C, Neagu M, Zurac SA and
Boda D: In vivo confocal laser scanning microscopy imaging of skin
inflammation: Clinical applications and research directions. Exp
Ther Med. 17:1004–1011. 2019.PubMed/NCBI View Article : Google Scholar
|
6
|
Caruntu C, Boda D, Caruntu A, Rotaru M,
Baderca F and Zurac S: In vivo imaging techniques for psoriatic
lesions. Rom J Morphol Embryol. 55: (Suppl 3):1191–1196.
2014.PubMed/NCBI
|
7
|
Chiricozzi A, Romanelli P, Volpe E,
Borsellino G and Romanelli M: Scanning the immunopathogenesis of
psoriasis. Int J Mol Sci. 19:179–210. 2018.PubMed/NCBI View Article : Google Scholar
|
8
|
Özkesici-Kurt B, Donmez L, Nazlim B,
Bozkurt S, Akman-Karakaş A, Yilmaz E and Alpsoy E: Defining the
natural course of psoriasis: A single-center cohort study of 100
patients. Turk J Dermatol. 12:33–37. 2018.
|
9
|
Hsu PY, Yen HH, Yang TH and Su CC:
Tetrathiomolybdate, a copper chelator inhibited imiquimod-induced
skin inflammation in mice. J Dermatol Sci. 92:30–37.
2018.PubMed/NCBI View Article : Google Scholar
|
10
|
Rozis G, Benlahrech A, Duraisingham S,
Gotch F and Patterson S: Human Langerhans' cells and dermal-type
dendritic cells generated from CD34 stem cells express different
toll-like receptors and secrete different cytokines in response to
toll-like receptor ligands. Immunology. 124:329–338.
2008.PubMed/NCBI View Article : Google Scholar
|
11
|
Negrei C, Arsene AL, Toderescu CD, Boda D
and Ilie M: Acitretin treatment may influence the cell membrane
fluidity. Farmacia. 60:767–772. 2012.
|
12
|
Batani A, Brănișteanu DE, Ilie MA, Boda D,
Ianosi S, Ianosi G and Caruntu C: Assessment of dermal papillary
and microvascular parameters in psoriasis vulgaris using in vivo
reflectance confocal microscopy. Exp Ther Med. 15:1241–1246.
2018.PubMed/NCBI View Article : Google Scholar
|
13
|
Fekete GL, Cotoi OS and Fekete JE:
Multiple nodular cutaneous metastases as the first clinical sign of
signet ring cell gastric carcinoma: Case report. Acta
Dermatovenerol Croat. 20:34–37. 2012.PubMed/NCBI
|
14
|
Fekete GL and Fekete L: Cutaneous
leukocytoclastic vasculitis associated with erlotinib treatment: A
case report and review of the literature. Exp Ther Med.
17:1128–1131. 2019.PubMed/NCBI View Article : Google Scholar
|
15
|
Rendon MI, Berson DS, Cohen JL, Roberts
WE, Starker I and Wang B: Evidence and considerations in the
application of chemical peels in skin disorders and aesthetic
resurfacing. J Clin Aesthet Dermatol. 3:32–43. 2010.PubMed/NCBI
|
16
|
Ardeleanu V, Berbece SI, Florescu IP and
Jecan RC: The use of hyaluronic acid combined with teosyal
redensity II for the treatment of dark circles under the eyes.
Mater Plast. 54:37–40. 2017.
|
17
|
Jecan RC, Nicolau A, Florescu IP,
Ardeleanu V and Berbece S: Use of trichloroacetic acid in treating
facial hyperpigmentation. Mater Plast. 54:88–90. 2017.
|
18
|
Ardeleanu V, Dobre M and Georgescu EM:
Deep facial wrinkle treatment outcome after first injection of
reticulated hyaluronic acid. Rev Chim (Bucharest). 66:2129–2131.
2015.
|
19
|
De Boulle K and Heydenrych I: Patient
factors influencing dermal filler complications: Prevention,
assessment, and treatment. Clin Cosmet Investig Dermatol.
8:205–214. 2015.PubMed/NCBI View Article : Google Scholar
|
20
|
Bridgman AC and Kirchhof MG: Treatment of
psoriasis vulgaris using low-dose naltrexone. JAAD Case Rep.
4:827–829. 2018.PubMed/NCBI View Article : Google Scholar
|
21
|
Schadler ED, Ortel B and Mehlis SL:
Biologics for the primary care physician: Review and treatment of
psoriasis. Dis Mon. 65:51–90. 2019.PubMed/NCBI View Article : Google Scholar
|
22
|
Brănişteanu DE, Voicu CM, Creţu A,
Dimitriu A, Luca MC and Sălăvăstru CM: Adverse reactions of
biological therapy for psoriasis. Rev Med Chir Soc Med Nat Iasi.
119:38–44. 2015.PubMed/NCBI
|
23
|
Negrei C, Ginghină O, Caruntu C, Burcea
Dragomiroiu G, Jinescu G and Boda D: Investigation relevance of
methotrexate polyglutamates in biological systems by high
performance liquid chromatography. Rev Chim (Bucharest).
66:766–768. 2015.
|
24
|
Negrei C, Caruntu C, Ginghina O,
Dragomiroiu GT, Toderescu CD and Boda D: Qualitative and
quantitative determination of methotrexate polyglutamates in
erythrocytes by high performance liquid chromatography. Rev Chim
(Bucharest). 66:607–610. 2015.
|
25
|
Boda D, Negrei C, Nicolescu F and Badalau
C: Assessment of some oxidative stress parameters in methotrexate
treated psoriasis patients. Farmacia. 62:704–710. 2014.
|
26
|
Li Y, Zhang G, Chen M, Tong M, Zhao M,
Tang F, Xiao R and Wen H: Rutaecarpine inhibited imiquimod-induced
psoriasis-like dermatitis via inhibiting the NF-κB and TLR7
pathways in mice. Biomed Pharmacother. 109:1876–1883.
2019.PubMed/NCBI View Article : Google Scholar
|
27
|
Varma SR, Sivaprakasam TO, Mishra A,
Prabhu S, Rafiq M and Rangesh P: Imiquimod-induced psoriasis-like
inflammation in differentiated human keratinocytes: Its evaluation
using curcumin. Eur J Pharmacol. 813:33–41. 2017.PubMed/NCBI View Article : Google Scholar
|
28
|
Tatu AL, Ionescu MA and Nwabudike LC:
Contact allergy to topical mometasonefuroate confirmed by
rechallenge and patch test. Am J Ther. 25:e497–e498.
2018.PubMed/NCBI View Article : Google Scholar
|
29
|
Nwabudike LC and Tatu AL: Response to -
Chronic exposure to tetracyclines and subsequent diagnosis for
non-melanoma skin cancer in a large Mid-Western US population. J
Eur Acad Dermatol Venereol. 32(e159)2018.PubMed/NCBI View Article : Google Scholar
|
30
|
Brănișteanu DE, Ianoşi SL, Dimitriu A,
Stoleriu G, Oanţǎ A and Brănișteanu DC: Drug-induced Rowell
syndrome, a rare and difficult to manage disease: A case report.
Exp Ther Med. 15:785–788. 2018.PubMed/NCBI View Article : Google Scholar
|
31
|
Li YL, Du ZY, Li PH, Yan L, Zhou W, Tang
YD, Liu GR, Fang YX, Zhang K, Dong CZ, et al: Aromatic-turmerone
ameliorates imiquimod-induced psoriasis-like inflammation of BALB/c
mice. Int Immunopharmacol. 64:319–325. 2018.PubMed/NCBI View Article : Google Scholar
|
32
|
Zhang Y, Xia Q, Li Y, He Z, Li Z, Guo T,
Wu Z and Feng N: CD44 assists the topical anti-psoriatic efficacy
of curcumin-loaded hyaluronan-modified ethosomes: A new strategy
for clustering drug in inflammatory skin. Theranostics. 9:48–64.
2019.PubMed/NCBI View Article : Google Scholar
|
33
|
Arora N, Shah K and Pandey-Rai S:
Inhibition of imiquimod-induced psoriasis-like dermatitis in mice
by herbal extracts from some Indian medicinal plants. Protoplasma.
253:503–515. 2016.PubMed/NCBI View Article : Google Scholar
|
34
|
Wu DH, Zhang MM, Li N, Li X, Cai QW, Yu
WL, Liu LP, Zhu W and Lu CJ: PSORI-CM02 alleviates IMQ-induced
mouse dermatitis via differentially regulating pro- and
anti-inflammatory cytokines targeting of Th2 specific transcript
factor GATA3. Biomed Pharmacother. 110:265–274. 2019.PubMed/NCBI View Article : Google Scholar
|
35
|
Hosseini A and Hosseinzadeh H: Antidotal
or protective effects of Curcuma longa (turmeric) and its
active ingredient, curcumin, against natural and chemical
toxicities: A review. Biomed Pharmacother. 99:411–421.
2018.PubMed/NCBI View Article : Google Scholar
|
36
|
Valizadeh Kiamahalleh M, Najafpour-Darzi
G, Rahimnejad M, Moghadamnia AA and Valizadeh Kiamahalleh M: High
performance curcumin subcritical water extraction from turmeric
(Curcuma longa L.). J Chromatogr B Analyt Technol Biomed
Life Sci. 1022:191–198. 2016.PubMed/NCBI View Article : Google Scholar
|
37
|
Tasneem S, Liu B, Li B, Choudhary MI and
Wang W: Molecular pharmacology of inflammation: Medicinal plants as
anti-inflammatory agents. Pharmacol Res. 139:126–140.
2019.PubMed/NCBI View Article : Google Scholar
|
38
|
Mahomoodally MF, Protab K and Aumeeruddy
MZ: Medicinal plants brought by Indian indentured immigrants: A
comparative review of ethnopharmacological uses between Mauritius
and India. J Ethnopharmacol. 234:245–289. 2019.PubMed/NCBI View Article : Google Scholar
|
39
|
Tatu AL and Cristea VC: Unilateral
blepharitis with fine follicular scaling. J Cutan Med Surg.
21(442)2017.PubMed/NCBI View Article : Google Scholar
|
40
|
Gheorghe I, Tatu AL, Lupu I, Thamer O,
Cotar AI, Pircalabioru GG, Popa M, Cristea VC, Lazar V and
Chifiriuc MC: Molecular characterization of virulence and
resistance features in Staphylococcus aureus clinical
strains isolated from cutaneous lesions in patients with drug
adverse reactions. Rom Biotechnol Lett. 22:12321–12327. 2017.
|
41
|
Kubiak K, Sielawa H, Chen W and Dzika E:
Endosymbiosis and its significance in dermatology. J Eur Acad
Dermatol Venereol. 32:347–354. 2018.PubMed/NCBI View Article : Google Scholar
|
42
|
Kar SK and Bera TK: Phytochemical
constituents of Aloe vera and their multifunctional
properties: A comprehensive review. Int J Pharm Sci Res.
9:1416–1423. 2018.
|
43
|
El-Gammal A, Nardo VD, Daaboul F, Tchernev
G, Wollina U, Lotti J and Lotti T: Is there a place for local
natural treatment of psoriasis? Open Access Maced J Med Sci.
6:839–842. 2018.PubMed/NCBI View Article : Google Scholar
|
44
|
Dhanabal SP, Priyanka Dwarampudi L,
Muruganantham N and Vadivelan R and Vadivelan R: Evaluation of the
antipsoriatic activity of Aloe vera leaf extract using a
mouse tail model of psoriasis. Phytother Res. 26:617–619.
2012.PubMed/NCBI View
Article : Google Scholar
|
45
|
Yue L, Ailin W, Jinwei Z, Leng L, Jianan
W, Li L, Haiming C, Ling H and Chuanjian L: PSORI-CM02 ameliorates
psoriasis in vivo and in vitro by inducing autophagy via inhibition
of the PI3K/Akt/mTOR pathway. Phytomedicine.
64(153054)2019.PubMed/NCBI View Article : Google Scholar
|
46
|
Mihăilă B, Dinică RM, Tatu AL and Buzia
OD: New insights in vitiligo treatments using bioactive compounds
from Piper nigrum. Exp Ther Med. 17:1039–1044.
2019.PubMed/NCBI View Article : Google Scholar
|
47
|
Buzia OD, Fasie V, Mardare N, Diaconu C,
Gurau G and Tatu AL: Formulation, preparation, physico-chimical
analysis, microbiological peculiarities and therapeutic challenges
of extractive solution of Kombucha. Rev Chim (Bucharest).
69:720–724. 2018.
|
48
|
Tatu AL and Ionescu MA: Multiple
autoimmune syndrome type III thyroiditis, vitiligo and alopecia
areata. Acta Endocrinol (Buchar). 13:124–125. 2017.PubMed/NCBI View Article : Google Scholar
|
49
|
Brănişteanu DE, Pintilie A, Andreş LE,
Dimitriu A, Oanţă A, Stoleriu G and Brănişteanu DC: Ethiopatogenic
hypotheses in lichen planus. Rev Med Chir Soc Med Nat Iasi.
120:760–767. 2016.PubMed/NCBI
|
50
|
Niculet E, Neculia GV, Tatu AL and Buzia
OD: Curcumin- extraction, physical and chemical analysis, formulas
and control. Basic methods for further research. Mater Plast.
55:672–675. 2018.
|
51
|
Buzia OD, Mardare N, Dragomir R, Miulescu
M and Tatu AL: Pharmaceutical forms with basil and propolis to the
benefit of the oral cavity, formulation, preparation and
microbiological analysis. Rev Chim (Bucharest). 70:343–349.
2019.
|
52
|
Branisteanu DE, Pintilie A, Dimitriu A,
Cerbu A, Ciobanu D, Oanta A and Tatu AL: Clinical, laboratory and
therapeutic profile of lichen planus. Rev Med Chir Soc Med Nat
Iasi. 121:25–32. 2017.
|
53
|
Tatu AL and Nwabudike LC: The treatment
options of male genital lichen sclerosus et atrophicus short title
for a running head: Treatments of genital lichen sclerosus. In:
Proceedings of the 14th National Congress of Urogynecology and the
National Conference of the Romanian Association for the Study of
Pain, pp262-264, 2017.
|
54
|
Nwabudike LC and Tatu AL: Using
complementary and alternative medicine for the treatment of
psoriasis: A step in the right direction. JAMA Dermatol.
155:636–637. 2019.PubMed/NCBI View Article : Google Scholar
|
55
|
Brănişteanu DE, Brănişteanu DC, Stoleriu
G, Ferariu D, Voicu CM, Stoica LE, Căruntu C, Boda D,
Filip-Ciubotaru FM, Dimitriu A, et al: Histopathological and
clinical traps in lichen sclerosus: A case report. Rom J Morphol
Embryol. 57 (Suppl 2):817–823. 2016.PubMed/NCBI
|
56
|
Herman A and Herman AP: Topically used
herbal products for the treatment of psoriasis - mechanism of
action, drug delivery, clinical studies. Planta Med. 82:1447–1455.
2016.PubMed/NCBI View Article : Google Scholar
|